* Health and Medical News:This biotech stock is a bargain: Strategist

Options expert Stacey Gilbert explains why Celgene is trading at a discount to its peers.

from @ Health and Medical News http://ift.tt/1EDifwV
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...

Popular Health News